Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Mochel

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Human Pathology|April 3, 2025
CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with cylindroma-like morphology and adverse clinical featuresXiaoqin Zhu, Xiuling Meng, Mark C Mochel, et al.
Journal of Cutaneous Pathology|August 9, 2024
Cutaneous Rosai-Dorfman disease with MAP2K1 mutation, initially mimicking an infection with parasitized histiocytesJoseph Gillam, Ruchi Desai, Raphael J Louie, et al.
Journal of the American Academy of Dermatology|July 21, 2015
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patientsMark C Mochel, Marc R Hammond, Dennie T Frederick, et al.
Journal of Cutaneous Pathology|May 11, 2016
Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanomaMark C Mochel, Michael E Ming, Sotonye Imadojemu, et al.
The American Journal of Surgical Pathology|July 29, 2023
Malignant Proliferating Pilar Tumor: Clinicopathologic, Immunohistochemical, and Molecular Study of 17 CasesJakob M T Moran, Mia S DeSimone, Adrián Mariño-Enríquez, et al.
Cancers|April 3, 2021
Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive ProfilesPiotr Donizy, Joanna P Wróblewska, Dora Dias-Santagata, et al.
Histopathology|June 30, 2020
Genital verruciform xanthoma: lessons from a contemporary multi-institutional seriesGrace Wang, Mark C Mochel, M Barry Randall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2020
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic featuresErik A Williams, Meagan Montesion, Brian M Alexander, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2021
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation statusXiaoqin Zhu, Sarah Jamshed, Jian Zou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesErik A Williams, Nikunj Shah, Meagan Montesion, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Human Pathology|April 3, 2025
CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with cylindroma-like morphology and adverse clinical featuresXiaoqin Zhu, Xiuling Meng, Mark C Mochel, et al.
Journal of Cutaneous Pathology|August 9, 2024
Cutaneous Rosai-Dorfman disease with MAP2K1 mutation, initially mimicking an infection with parasitized histiocytesJoseph Gillam, Ruchi Desai, Raphael J Louie, et al.
Journal of the American Academy of Dermatology|July 21, 2015
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patientsMark C Mochel, Marc R Hammond, Dennie T Frederick, et al.
Journal of Cutaneous Pathology|May 11, 2016
Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanomaMark C Mochel, Michael E Ming, Sotonye Imadojemu, et al.
The American Journal of Surgical Pathology|July 29, 2023
Malignant Proliferating Pilar Tumor: Clinicopathologic, Immunohistochemical, and Molecular Study of 17 CasesJakob M T Moran, Mia S DeSimone, Adrián Mariño-Enríquez, et al.
Cancers|April 3, 2021
Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive ProfilesPiotr Donizy, Joanna P Wróblewska, Dora Dias-Santagata, et al.
Histopathology|June 30, 2020
Genital verruciform xanthoma: lessons from a contemporary multi-institutional seriesGrace Wang, Mark C Mochel, M Barry Randall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2020
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic featuresErik A Williams, Meagan Montesion, Brian M Alexander, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2021
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation statusXiaoqin Zhu, Sarah Jamshed, Jian Zou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesErik A Williams, Nikunj Shah, Meagan Montesion, et al.
Pageof 5